BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 2021;6:162. [PMID: 33907179 DOI: 10.1038/s41392-021-00553-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tahir AH, Li JJ, Tang Y. Peripheral and Spinal Mechanisms Involved in Electro-Acupuncture Therapy for Visceral Hypersensitivity. Front Neurosci 2021;15:696843. [PMID: 34658755 DOI: 10.3389/fnins.2021.696843] [Reference Citation Analysis]
2 Zou L, Collins HE, Young ME, Zhang J, Wende AR, Darley-usmar VM, Chatham JC. The Identification of a Novel Calcium-Dependent Link Between NAD+ and Glucose Deprivation-Induced Increases in Protein O-GlcNAcylation and ER Stress. Front Mol Biosci 2021;8:780865. [DOI: 10.3389/fmolb.2021.780865] [Reference Citation Analysis]
3 Penolazzi L, Bergamin LS, Lambertini E, Poma VV, Sarti AC, De Bonis P, Di Virgilio F, Piva R. The P2X7 purinergic receptor in intervertebral disc degeneration. J Cell Physiol 2021. [PMID: 34668208 DOI: 10.1002/jcp.30611] [Reference Citation Analysis]
4 Savio LEB, Leite-Aguiar R, Alves VS, Coutinho-Silva R, Wyse ATS. Purinergic signaling in the modulation of redox biology. Redox Biol 2021;47:102137. [PMID: 34563872 DOI: 10.1016/j.redox.2021.102137] [Reference Citation Analysis]
5 Ye SS, Tang Y, Song JT. ATP and Adenosine in the Retina and Retinal Diseases. Front Pharmacol 2021;12:654445. [PMID: 34211393 DOI: 10.3389/fphar.2021.654445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cano-Martínez A, Bautista-Pérez R, Castrejón-Téllez V, Carreón-Torres E, Pérez-Torres I, Díaz-Díaz E, Flores-Estrada J, Guarner-Lans V, Rubio-Ruíz ME. Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. Int J Mol Sci 2021;22:8939. [PMID: 34445644 DOI: 10.3390/ijms22168939] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li Z, Zhang J, Ai HW. Genetically Encoded Green Fluorescent Biosensors for Monitoring UDP-GlcNAc in Live Cells. ACS Cent Sci 2021;7:1763-70. [PMID: 34729420 DOI: 10.1021/acscentsci.1c00745] [Reference Citation Analysis]
8 Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]
9 Zuccarini M, Lambertucci C, Carluccio M, Giuliani P, Ronci M, Spinaci A, Volpini R, Ciccarelli R, Di Iorio P. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands. Cells 2021;10:3560. [PMID: 34944069 DOI: 10.3390/cells10123560] [Reference Citation Analysis]
10 Zou Y, Yang R, Li L, Xu X, Liang S. Purinergic signaling: a potential therapeutic target for depression and chronic pain. Purinergic Signal 2021. [PMID: 34338957 DOI: 10.1007/s11302-021-09801-x] [Reference Citation Analysis]
11 Yin HY, Fan YP, Liu J, Li DT, Guo J, Yu SG. Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model. Purinergic Signal 2021. [PMID: 34378078 DOI: 10.1007/s11302-021-09815-5] [Reference Citation Analysis]
12 Wu Z, Tan J, Zhuang Y, Zhong M, Xiong Y, Ma J, Yang Y, Gao Z, Zhao J, Ye Z, Zhou H, Zhu Y, Lu H, Hong X. Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis. Cancer Cell Int 2021;21:668. [PMID: 34906153 DOI: 10.1186/s12935-021-02385-x] [Reference Citation Analysis]
13 Xu G, Zhang S, Zheng L, Hu Z, Cheng L, Chen L, Li J, Shi Z. In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations. Purinergic Signal 2021. [PMID: 34677752 DOI: 10.1007/s11302-021-09808-4] [Reference Citation Analysis]
14 Lau CC, Aminuddin A, Chan KM, Paterson IC, Law LM, Ng PY. Extracellular ATP Induced S-Phase Cell Cycle Arrest via P2Y Receptor-Activated ERK Signaling in Poorly Differentiated Oral Squamous Cell Carcinoma SAS Cells. Life (Basel) 2021;11:1170. [PMID: 34833046 DOI: 10.3390/life11111170] [Reference Citation Analysis]